New Method for Noninvasive Detection of Circulating Tumor Cells in Blood
The technique uses two laser sources and detectors to mitigate noise and autofluorescence, and may help detect fluorescent tags.
Read MorePosted by Andy Lundin | Jul 24, 2023 | Cancer, Flow Cytometry |
The technique uses two laser sources and detectors to mitigate noise and autofluorescence, and may help detect fluorescent tags.
Read MorePosted by Andy Lundin | Jul 18, 2023 | Prostate |
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2023 | Company News |
EDP Biotech Corp. and New Day Diagnostics LLC announced their strategic merger, joining together to focus on the expedited development and commercialization of diagnostic tests.
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2023 | Prostate |
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Lung Cancer |
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More